熱門資訊> 正文

Quince Therapeutics偿还了1600万美元EIB债务;股价飙升18%

2026-03-30 21:45

Quince Therapeutics, Inc.(QNCX) 0

Quince Therapeutics (QNCX) settled its outstanding ~$16.4M EIB loan at a discounted payoff of $5.5M, reducing its debt balance sheet.
CEO & CMO Dirk Thye said the company had settled its EIB debt to allow more flexibility to explore options like mergers, asset sales, or other deals to enhance shareholder value.
As of March 30, 2026, Quince Therapeutics (QNCX) is trading at $0.10, up 18.61%.

More on Quince Therapeutics

Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential
Seeking Alpha’s Quant Rating on Quince Therapeutics
Historical earnings data for Quince Therapeutics
Financial information for Quince Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。